HHS is moving forward with drug price negotiations afforded to CMS under the Inflation Reduction Act.

The U.S. Food and Drug Administration (FDA) approved a new drug treatment for Alzheimer’s disease, Leqembi (lecanemab).

Amazon has overcome another step toward acquiring primary care group One Medical for $3.9 billion after the Oregon Housing Authority cleared the deal.

GE has completed the spinoff of its healthcare business, and GE HealthCare began trading as its own entity on the Nasdaq Jan. 4.

The American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine) has released new guidelines surrounding cannabis use in relation to surgery, advocating for all patients undergoing procedures with anesthesia to be screened for cannabis use.

Seven members have been added to the Health Information Technology Advisory Committee (HITAC), a group tasked with improving the quality and access of health IT by the Government Accountability Office (GAO).

The American Medical Association said its members are "extremely disappointed and dismayed" that Congress did not act in time. The Medical Group Management Association shared a similar message. 

A wave of infections across the United States has led to a run on certain over-the-counter medications, and some retailers are limiting purchases to deal with the seasonal demand.